Sinocare Overview
- Year Founded
-
2002
- Status
-
Public
- Employees
-
5,010
- Stock Symbol
-
300298
- Investments
-
15
- Share Price
-
$2.50
- (As of Friday Closing)
Sinocare General Information
Description
Sinocare Inc operates in the healthcare industry. It is engaged in the development, manufacturing, and marketing of diagnosis testing products for people with chronic diseases and healthcare professionals. Its product range covers household blood glucose meter, medical blood glucose meter, urinary microalbumin test strip and blood lipid uric acid products. In addition, the company also provides diabetes management information systems.
Contact Information
Website
www.en.sinocare.comCorporate Office
- No.265, Guyuan Road, Hi-tech Zone
- Changsha, Hunan 410205
- China
Corporate Office
- No.265, Guyuan Road, Hi-tech Zone
- Changsha, Hunan 410205
- China
Sinocare Stock Performance
As of 20-Nov-2026, Sinocare’s stock price is $2.50. Its current market cap is $1.39B with 557M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.50 | $2.60 | $1.97 - $2.91 | $1.39B | 557M | 7.58M | $0.07 |
Sinocare Financials Summary
As of 30-Sep-2026, Sinocare has a trailing 12-month revenue of $732M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,394,081 | 1,393,656 | 2,070,639 | 2,533,971 |
| Revenue | 732,108 | 647,911 | 619,211 | 573,690 |
| EBITDA | 50,223 | 40,120 | 88,879 | 70,867 |
| Net Income | 36,743 | 12,883 | 45,473 | 40,198 |
| Total Assets | 926,030 | 852,148 | 835,271 | 836,127 |
| Total Debt | 157,920 | 118,461 | 113,863 | 152,054 |
Sinocare Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sinocare Comparisons
Industry
Financing
Details
Sinocare Competitors (3)
One of Sinocare’s 3 competitors is Yuwell, a Corporation company based in Rottweil, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Yuwell | Corporation | Rottweil, Germany | ||||
| DexCom | Formerly VC-backed | San Diego, CA | ||||
| Vivachek | Venture Capital-Backed | Hangzhou, China |
Sinocare Patents
Sinocare Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023010647-A1 | Ctni antibody-coated magnetic bead preservation solution and preparation method therefor | Inactive | 06-Aug-2021 | ||
| WO-2023004614-A1 | Method and system for correcting current signal | Inactive | 28-Jul-2021 | ||
| WO-2022233106-A1 | Preparation method for alkaline phosphatase-labelled thyroxine | Inactive | 06-May-2021 | ||
| WO-2022205774-A1 | Detection kit for procalcitonin, and preparation method therefor | Inactive | 02-Apr-2021 | ||
| WO-2022160722-A1 | Test strip insertion identification apapratus and method, and test strip sample absorption determination apapratus and method | Inactive | 27-Jan-2021 | G01N27/12 |
Sinocare Signals
Sinocare Investments & Acquisitions (15)
Sinocare’s most recent deal was a Joint Venture with SINOFLOW Company. The deal was made on 26-Jan-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| SINOFLOW Company | 26-Jan-2022 | Joint Venture | Therapeutic Devices | ||
| EOFlow | 26-Oct-2021 | PIPE | Drug Delivery | ||
| Cellomics International | 24-Sep-2021 | Later Stage VC | Diagnostic Equipment | ||
| Seamaty | 23-Feb-2021 | Secondary Transaction - Private | Diagnostic Equipment | ||
| SPH Health Commerce | 18-Jan-2021 | Later Stage VC | Other Pharmaceuticals and Biotechnology |
Sinocare ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
32.19 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Sinocare Exits (3)
Sinocare’s most recent exit was on 07-Nov-2018 from Dnurse. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Dnurse | 07-Nov-2018 | Completed |
|
||
| Dnurse | 07-Feb-2014 | Completed |
|
||
| Dnurse | 01-Sep-2013 | Seed Round | Completed |
|
Sinocare Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| PTS Diagnostics | Whitestown, IN | 1992 |
Sinocare FAQs
-
When was Sinocare founded?
Sinocare was founded in 2002.
-
Where is Sinocare headquartered?
Sinocare is headquartered in Changsha, China.
-
What is the size of Sinocare?
Sinocare has 5,010 total employees.
-
What industry is Sinocare in?
Sinocare’s primary industry is Diagnostic Equipment.
-
Is Sinocare a private or public company?
Sinocare is a Public company.
-
What is Sinocare’s stock symbol?
The ticker symbol for Sinocare is 300298.
-
What is the current stock price of Sinocare?
As of 20-Nov-2026 the stock price of Sinocare is $2.50.
-
What is the current market cap of Sinocare?
The current market capitalization of Sinocare is $1.39B.
-
What is Sinocare’s current revenue?
The trailing twelve month revenue for Sinocare is $732M.
-
Who are Sinocare’s competitors?
-
What is Sinocare’s annual earnings per share (EPS)?
Sinocare’s EPS for 12 months was $0.07.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process